retour à la homepage
logo CHUV
Qui sommes-nous ? Prestations de formation Prestations de laboratoire Recherche & développement  Liens  News & actualités   
français  |  english home < Recherche & développement < Publications < Posters Plan d'accèsPlan du siteImprimer
Recherche & développement
Fondation StopDoping
Projets actuels
Projets finalisés
Publications
Articles
Posters
Autres
Chapitres de livre
Thèses

Posters scientifiques

La liste ci-dessous mentionne les auteurs et les titres des principaux posters créés par les scientifiques du LAD dans le cadre des différents travaux de recherche.

2012

  • Piper T., Emery C, Saugy M.
    Improved sample preparation and subsequent investigations on and changes in reference population based thresholds for carbon isotope ratios of urinary steroids ( 347 Ko)

  • Piper T., Emery C, Saugy M.
    Norandrosterone analysis by GC/C/IRMS ( 527 Ko)

2011

  • Badoud F., Grata E., Boccard J., Rudaz S., Veuthey J.L., Saugy M.
    Profiling endogenous steroids by UHPLC-QTOF-MSE ( 527 Ko)

  • Leuenberger N., Jan N., Pradervand S., Robinson N., Saugy M.
    Circulating microRNAs as stable Biomarkers for the Detection of Erythropoiesis-Stimulating Agent Abuse ( 541Ko)

  • Emery C., Grata E., Saugy M.
    HPLC fractionation methods for isolation of endogenous urinary steroids prior to GC/C/IRMS analysis ( 441 Ko)

2010

  • Marclay F. and Saugy M
    Determination of nicotine metabolite in urine by liquid chromatography mass spectroscopy : trends of tobacco products use in ice hockey ( 262 Ko)

.

2009

  • Marclay F.,Pazos D., Délemont P., Esseiva P., Saudan C.
    Potential of IRMS technology for tracing gamma-butyrolactone (GLB). ( 370 Ko)

  • Perrenoud L, Grata E, Baume N, Saugy M, Saudan C.
    Detection and characterization of 4-Methyl-Hexanamine, a stimulant analogue. ( 100 Ko)^

  • Strahm E, Sottas PE, Schweizer C, Saugy M, Saudan C.
    Steroid profiles of professional athletes : an international comparative study. ( 120 Ko)

2008

  • Avois L, Bailloux I, Desmarcheliers A, Lahaussois A, Méchin N, Saugy M, de Ceaurriz J.
    Clinical study: Criteria setting for the misuse of glucocorticoids.( 1.1 Mo)
     
  • Badoud F, Grata E, Perrenoud L, Mateus-Avois L, Saugy M, Rudaz S, Veuthey JL.
    Fast screening of 115 doping agents in urine using 96-well plate solid phase extraction and UPLC-qTOF-MS ( 230 Ko)
     
  • Lamon S, Robinson N, Sottas PE, Henry H, Kamber M, Mangin P, Saugy M.
    Possible origins of undetectable EPO in urine samples ( 1.0 Mo)
     
  • Saudan C, Augsburger M, Mangin P, Saugy M.
    Carbon isotopic ratio analysis by GC/C/IRMS for the detection of gamma-hydroxybutyric  acid (GHB) administration to human ( 180 Ko)
     
  • Sottas PE, Robinson N, Mangin P, Saugy M.
    Indirect markers of blood doping. ( 800 Ko)
     
  • Strahm E, Perrenoud A, Saugy M, Saudan C.
    Analytical strategy to increase sensitivity for the quantification of endogenous steroids glucuronide in human urine using LC-MS/MS. ( 81 Ko)

2007

  • Avois L, Bailloux I, Desmarcheliers A, Lahaussois A, Méchin N, Saugy M, de Ceaurriz J.
    Synthetic glucocorticosteroids administration: urinary excretion study of triamcinolone acetonide ( 200 Ko)
     

2006

  • Baume N, Saudan C, Desmarcheliers A, Strahm E, Sottas PE, Bagutti C, Cauderay M, Schumacher YO, Mangin M, Saugy M.
    Use of isotope ratio mass spectrometry to detect doping with oral testosterone undecanoate: Inter-individual variability of 13C/12C ratio ( 420 Ko)
     

2005

  • Mateus-Avois L, Saugy M.
    Optimization of morphine and codeine hydrolysis ini urine by experimental design for GC-MS quantification purpose ( 420 Ko)
     
  • Mateus-Avois L, Schweizer C, Saugy M.
    Dosage of nandrolone metabolites in urine after the therapeutic administration of an ophtalmic solution ( 290 Ko)
     

2004

  • Baume N, Avois L, Cauderay M, Dvorak J, Mangin P, Saugy M.
    13C-labelled nandrolone excretion in trained athletes during exercise ( 380 Ko)
     
  • Baume N, Kamber M, Mangin P, Saugy M.
    Research of stimulants and anabolic steroids in nutritional supplements ( 590 Ko)
     
  • Maître A, Schweizer C, Saudan C, Mangin P, Saugy M.
    Testosterone Excretion Study Monitored by Gas Chromatography/Combustion/Isotope Ratio Mass Spectrometry ( 530 Ko)
     
  • Mateus-Avois L, Mangin P, Saugy M.
    Identification of 3'hydroxystanozolol in urine by GC-MS3: a case report ( 300 Ko)
     
  • Mateus-Avois L, Mangin P, Saugy M.
    Rapid screening of HES in urine eith colorimetric detection ( 380 Ko)
     
  • Robinson N, Zotter H, Mangin P, Saugy M.
    Evolution of biomedical profiles in professional cycling during the three main tours ( 670 Ko)
     
  • Saudan C, Robinson N, Mangin P, Saugy M.
    Mass spectrometry: A new technique to tackle abuse of erythropoietin (EPO) in sport ( 1.3 Mo)
     

2003

  • Maître A, Schweizer C, Mangin P, Saugy M.
    IRMS for solving T/E>6 cases, how useful is it? ( 720 Ko)
     
  • Mateus-Avois L, Mangin P, Saugy M.
    Development and validation of a capillary electrophoresis method for the determination of ephedrine and related compounds in urine without extraction ( 150 Ko)
     
  • Robinson N, Pfister Y, Mangin P, Saugy M.
    One year's experiment with the blood screening test to fight against rh-EPO doping ( 220 Ko)
     
  • Schweizer C, Mangin P, Saugy M.
    High amount of salbutamol: a case report ( 440 Ko)

 

Dernière modification le 07.03.2012

Retour haut de page